Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: Functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice

Journal of Virology

Volumn 79, Issue 23, 2005, Pages 14933-14944

  Tumpey, Terrence M ^a   García Sastre, Adolfo ^b   Taubenberger, Jeffery K ^c   Palese, Peter ^b   Swayne, David E ^d   Pantin Jackwood, Mary J ^d   Schultz Cherry, Stacey ^e   Solórzano, Alicia ^b   Van Rooijen, Nico ^f   Katz, Jacqueline M ^a   Basler, Christopher F ^b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS GLYCOPROTEIN; VIRUS SIALIDASE;

ADAPTATION; ANIMAL CELL; ARTICLE; CYTOKINE RELEASE; FEMALE; GENETIC ANALYSIS; IMMUNE RESPONSE; INFLUENZA VIRUS; LETHALITY; LUNG ALVEOLUS MACROPHAGE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; NOSE INFECTION; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIROGENESIS; VIRUS GENE; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HISTORY, 19TH CENTURY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUNG; MACROPHAGES; MICE; NEURAMINIDASE; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; VIRUS REPLICATION;

ANIMALIA; INFLUENZA VIRUS;

EID: 27744598497     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.23.14933-14944.2005     Document Type: Article

References (77)

1. Ada, G. L., and P. D. Jones. 1986. The immune response to influenza infection. Curr. Top. Microbiol. Immunol. 128:1-54.
2. Azoulay, E., M. Darmon, C. Delclaux, F. Fieux, C. Bornstain, D. Moreau, H. Attalah, J.-R. Le Gall, and B. Schlemmer. 2002. Deterioration of previous acute lung injury during neutropenia recovery. Crit. Care Med. 30:781-786.
3. Barbeito, M. S., G. Abraham, M. Best, P. Cairns, P. Langevin, W. G. Sterritt, D. Barr, W. Meulepas, J. M. Sanchez-Vizcaino, and M. Saraza. 1995. Recommended biocontainment features for research and diagnostic facilities where animal pathogens are used. First International Veterinary Biosafety Workshop. Rev. Sci. Tech. 14:873-887.
4. Basler, C. F., A. H. Reid, J. K. Dybing, T. A. Janczewski, T. G. Fanning, H. Zheng, M. Salvatore, M. L. Perdue, D. E. Swayne, A. Garcia-Sastre, P. Palese, and J. K. Taubenberger. 2001. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc. Natl. Acad. Sci. USA 98:2746-2751.
5. Brough-Holub, E., G. B. Toews, J. F. van Iwaarden, R. M. Stricter, S. L. Kunkel, R. Paine, and T. J. Standiford. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect. Immun. 65:1139-1146.
6. Cheung, C. Y., L. L. Poon, A. S. Lau, W. Luk, Y. L. Lau, K. F. Shortridge, S. Gordon, Y. Guan, and J. S. Peiris. 2002. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360:1831-1837.
7. Conn, C. A., J. L. McClellan, H. F. Maassab, C. W. Smitka, J. A. Majde, and M. J. Kluger. 1995. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268:R78-R84.
8. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583-1585.
9. Crosby, A. 1989. America's forgotten pandemic. Cambridge University Press, Cambridge, United Kingdom.
10. Doherty, P. C., W. Allan, M. Eichelberger, and S. R. Carding. 1992. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123-151.
11. Dunn, A. J., J. Wang, and T. Ando. 1999. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol. 461:117-127.
12. Ellis, T. N., and B. L. Beaman. 2004. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 112:2-11.
13. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571.
14. Fodor, E., L. Devenish, O. G. Engelhardt, P. Palese, G. G. Brownlee, and A. Garcia-Sastre. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679-9682.
15. Frost, W. 1920. Statistics of influenza morbidity. Public Health Rep. 35:584-597.
16. Fujisawa, H., S. Tsuru, M. Taniguchi, Y. Zinnaka, and K. Nomoto. 1987. Protective mechanisms against pulmonary infection with influenza virus. I. Relative contribution of polymorphonuclear leukocytes and of alveolar macrophages to protection during the early phase of intranasal infection. J. Gen. Virol. 68:425-432.
17. Fujisawa, H. 2001. Inhibitory role of neutrophils on influenza virus multiplication in the lungs of mice. Microbiol. Immunol. 45:679-688.
18. Ganz, T., M. E. Selsted, D. Szklarek, S. S. Harwig, K. Daher, D. F. Bainton, and R. I. Lehrer. 1985. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Investig. 76:1427-1435.
19. Geiss, G. K., M. Salvatore, T. M. Tumpey, V. S. Carter, X. Wang, C. F. Basler, J. K. Taubenberger, R. E. Bumgarner, P. Palese, M. G. Katze, and A. Garcia-Sastre. 2002. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. USA 99:10736-10741.
20. Gerhard, W., K. Mozdanowska, M. Furchner, G. Washko, and K. Maiese. 1997. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159:95-103.
21. Glaser, L., J. Stevens, D. Zamarin, I. A. Wilson, A. García- Sastre, T. M. Tumpey, C. F. Basler, J. K. Taubenberger, and P. Palese. 2005. A single amino acid substitution in the 1918 influenza virus hemagglutinin changes the receptor binding specificity. J. Virol. 79:11533-11536.
22. Goto, H., and Y. Kawaoka. 1998. A novel mechanism for the acquisition of virulence by a human influenza A virus. Proc. Natl. Acad. Sci. USA 95: 10224-10228.
23. Harmsen, A. G., B. A. Muggenburg, M. B. Snipes, and D. E. Bice. The role of macrophages in particle translocation from lungs to lymph nodes. Science 230:1277-1280.
24. Hartshorn, K. L., L. S. Liou, M. R. White, M. M. Kazhdan, J. L, Tauber, and A. I. Tauber. 1995. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J. Immunol. 154:3952-3960.
25. Hatta, M., P. Gao, P. Halfmann, and Y. Kawaoka. 2001. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840-1842.
26. Hayden, F. G, R. S. Fritz, M. Lobo, W. G. Alvord, W. Strober, and S. E. Straus. 1998. Local and systemic cytokine responses during experimental human influenza A virus infection. J. Clin. Investig. 101:643-649.
27. Kennet, T., H. J. Ziltener, K. Frei, and E. Peterhans. 1992. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J. Immunol. 149:932-939.
28. Hoyle, L. 1968. Adaptation of virus to mice, p. 170-171. In S. Gard, C. Hallauer, and K. F. Meyer (ed.), The influenza viruses. Springer-Verlag, New York, N.Y.
29. Jaeschke, H., A. Farhood, A. P. Bautista, Z. Spolarics, and J. J. Spitzer. 1993. Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am. J. Physiol. 264:G801-G809.
30. Kash, J. C., C. F. Basler, A. Garcia-Sastre, V. Carter, R. Billharz, D. E. Swayne, R. M. Przygodski, J. K. Taubenberger, M. Katze, and T. M. Tumpey. 2004. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J. Virol. 78:9499-9511.
31. Katz, J. M., X. Lu, S. A. Young, and J. C. Galphin. 1997. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J. Infect. Dis. 175:352-363.
32. Kilbourne, E. D. 1977. Influenza pandemics in perspective. JAMA 237:1225-1228.
33. Kips, J. C., J. H. Tavernier, and R. A. Pauwels. 1992. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145: 332-336.
34. Kobasa, D., A. Takada, K. Shinya, M. Hatta, P. Halfmann, S. Theriault, H. Suzuki, H. Nishimura, K. Mitamura, N. Sugaya, T. Usui, T. Murata, Y. Maeda, S. Watanabe, M. Suresh, T. Suzuki, Y. Suzuki, H. Feldmann, and Y. Kawaoka. 2004. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431:703-707.
35. LeCount, E. R. 1919. The pathologic anatomy of influenzal bronchopneumonia. JAMA 72:650-652.
36. Lu, X., T. M. Tumpey, T. Morken, S. R. Zaki, N. J. Cox, and J. M. Katz. 1999. A mouse model for the evaluation of pathogenesis and immunity to influenza A (HSN1) viruses isolated from humans. J. Virol. 73:5903-5911.
37. Mulligan, M. S., S. R. Watson, C. Fennie, and P. A. Ward. 1993. Protective effects of selectin chimeras in neutrophil-mediated lung injury. J. Immunol. 151:6410-6417.
38. Nagendra, S., and A. J. Schlueter. 2004. Absence of cross-reactivity between murine Ly-6C and Ly-6G. Cytometry 58:195-200.
39. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Investig. 79:319-326.
40. Noble, G. R. 1982. Epidemiological and clinical aspects of influenza, p. 11-50. In A. S. Beere (ed.), Basic and applied influenza research. CRC Press, Baton Rouge, Fla.
41. Ohmann, H. B., M. Campos, D. R. Fitzpatrick, N. Rapin, and L. A. Babiuk. 1989. A. neutrophil-derived antiviral protein: induction requirements and biological properties. J. Virol. 63:1916-1923.
42. Peiris, J. S., W. C. Yu, C. W. Leung, C. Y. Cheung, W. F. Ng, J. M. Nicholls, T. K. Ng, K. H. Chan, S. T. Lai, W. L. Lim, K. Y. Yuen, and Y. Guan. 2004. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363:617-619.
43. Pendino, K. J., J. D. Laskin, R. L. Shuler, C. J. Punjabi, and D. L. Laskin. 1993. Enhanced production of nitric oxide by rat alveolar macrophages after inhalation of a pulmonary irritant is associated with increased expression of nitric oxide synthase. J. Immunol. 151:7196-7205.
44. Perdue, M. L., and D. L. Suarez. 2000. Structural features of the avian influenza virus hemagglutinin that influence virulence. Vet. Microbiol. 74: 77-86.
45. Pestka, S., J. A. Langer, K. C. Zoon, and C. E. Samuel. 1987. Interferons and their actions. Annu. Rev. Biochem. 56:727.
46. Ratcliffe, D. R., S. L. Nolin, and E. B. Cramer. 1988. Neutrophil interaction with influenza-infected epithelial cells. Blood 72:142-149.
47. Reed, L. J., and H. Muench. 1938. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
48. Reid, A. H., T. G. Fanning, J. V. Hultin, and J. K. Taubenberger. 1999. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc. Natl. Acad. Sci. USA 96:1651-1656.
49. Reid, A. H., T. G. Fanning, T. A. Janczewski, and J. K. Taubenberger. 2000. Characterization of the 1918 "Spanish" influenza virus neuraminidase gene. Proc. Natl. Acad. Sci. USA 97:6785-6790.
50. Reid, A. H., J. K. Taubenberger, and T. G. Fanning. 2001. The 1918 Spanish influenza: integrating history and biology. Microbes Infect. 3:81-87.
51. Reid, A. H, T. G. Fanning, T. A. Janczewski, S. McCall, and J. K. Taubenberger. 2002. Characterization of the 1918 "Spanish" influenza virus matrix gene segment. J. Virol. 76:10717-10723.
52. Reid, A. H., T. G. Fanning, T. A. Janczewski, R. M. Lourens, and J. K. Taubenberger. 2004. Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. J. Virol. 78:12462-12470.
53. Rouse, B. T., L. A. Babiuk, and P. M. Henson. 1980. Neutrophils in antiviral immunity: inhibition of virus replication by a mediator produced by bovine neutrophils. J. Infect. Dis. 141:223-232.
54. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:471-501.
55. Simonet, W. S., T. M. Hughes, H. Q. Nguyen, L. D. Trebasky, D. M. Danilenko, E. S. Medlock, and S. Chapman. 1995. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J. Clin. Investig. 94:1310-1319.
56. Smith, J. A. 1994. Neutrophils, host defense, and inflammation: a double-edged sword. J. Leukoc. Biol. 56:672-686.
57. Swiergiel, A. H., and A. J. Dunn. 1999. The roles of IL-1, IL-6, and TNF-alpha in the feeding responses to endotoxin and influenza virus infection in mice. Brain Behav. Immun. 13:252-265.
58. Taubenberger, J. K., A. H. Reid, A. E. Krafft, K. E. Bijwaard, and T. G. Fanning. 1997. Initial genetic characterization of the 1918 "Spanish" influenza virus. Science 275:1793-1796.
59. Taubenberger, J. K., A. H. Reid, T. G. Fanning, and T. A. Janczewski. 2001. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos. Trans. R. Soc. Lond. B 356:1829-1839.
60. Thepen, T., N. van Rooijen, and G. Kraal. 1989. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 170:499-509.
61. Tsuru, S., H. Fujisawa, M. Taniguchi, Y. Zinnaka, and K. Nomoto. 1987. Mechanism of protection during the early phase of a generalized viral infection. II. Contribution of polymorphonuclear leukocytes to protection against intravenous infection with influenza virus. J. Gen. Virol. 68:419-424.
62. Tumpey, T. M., S.-H. Chen, J. E. Oakes, and R. N. Lausch. 1996. Neutrophil-mediated suppression of virus replication following herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:898-904.
63. Tumpey, T. M., X. Lu, T. Morken, S. R. Zaki, and J. M. Katz. 2000. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J. Virol. 74:6105-6116.
64. Tumpey, T. M., A. Garcia-Sastre, A. Mikulasova, J. K. Taubenberger, D. E. Swayne, P. Palese, and C. F. Basler. 2002. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 99:13849-13854.
65. Tumpey, T. M., A. Garcia-Sastre, J. K. Taubenberger, P. Palese, D. E. Swayne, and C. F. Basler. 2004. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl. Acad. Sci. USA 101:3166-3171.
66. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174:83-93.
67. van Strijp, J. A., K. P. van Kessel, L. A. Miltenburg, A. C. Fluit, and J. Verhoef. 1988. Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation. J. Virol. 62:847-850.
68. Wareing, M. D., A. B. Lyon, B. Lu, C. Gerard, and S. R. Sarawar. 2004. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J. Leukoc. Biol. 76:886-895.
69. Wijburg, O. L., S. DiNatale, J. Vadolas, N. van Rooijen, and R. A. Strugnell. 1997. Alveolar macrophages regulate the induction of primary cytotoxic T-lymphocyte responses during influenza virus infection. J. Virol. 71:9450-9457.
70. Wijburg, O. L., J. Vadolas, A. Sanders, R. A. Strugnell, and N. van Rooijen. 1998. The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens. Eur. J. Immunol. 28:479-487.
71. Winternitz, M. C., I. M. Wason, and F. P. McNamara. 1920. The pathology of influenza. Yale University Press, New Haven, Conn.
72. Wolbach, S. B. 1919. Comments on the pathology and bacteriology of fatal influenza cases, as observed at Camp Devens, Mass. Johns Hopkins Hosp. Bull. 30:104.
73. Wolpe, S. D., B. Sherry, D. Juers, G. Davatelis, R. W. Yurt, and A. Cerami. 1989. Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA 86:612-616.
74. Wright, P. F., and R. G. Webster. 2001. Orthomyxoviruses, p. 1533-1579. In D. M. Knipe, P. M. Howley, et al. Fields virology. Lippincott, Williams, and Wilkins, Philadelphia, Pa.
75. Xing, Z., M. Jordana, H. Kirpalani, K. E. Driscoll, T. J. Schall, and J. Gauldie. 1994. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation. Am. J. Respir. Cell Mol. Biol. 10:148-153.
76. Yamamoto, K., T. Miyoshi-Koshio, Y. Utsuki, S. Mizuno, and K. Suzuki. 1994. Virucidal activity and viral protein modification by myeloperoxidase: a candidate for defense factor of human polymorphonuclear leukocytes against influenza virus infection. J. Infect. Dis. 164:8-14.
77. Zhang, P., W. R. Summer, G. J. Bagby, and S. Nelson. 2000. Innate immunity and pulmonary host defense. Immunol. Rev. 173:39-51.